 CLEARWATER, Fla.--BUSINESS WIRE--Apyx Medical Corporation NASDAQ:APYX the Company, a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion and J-Plasma in surgical markets, today announced that financial results for the second quarter of fiscal year 2022 will be released after the market closes on Thursday, August 11th. Management will host a conference call at 5:00 p.m. Eastern Time on August 11th to discuss the results of 